Michael Schrader is the founder of Vaxess Technologies. Vaxess Technologies has raised $55M in total funding. Latest round: Series B.
Michael Schrader is the CEO and Co-founder of Vaxess Technologies, a life sciences company focused on developing a shelf-stable, sustained-release vaccine patch. Vaxess Technologies has raised over $55 million in funding from grants and venture capital. The company aims to make vaccines more accessible and eliminate the need for traditional needle injections.
Full founder directory · Investor directory · Company funding database · Fundraising library